Should High-Dose Interleukin-2 Still be the Preferred Treatment for Patients with Metastatic Renal Cell Cancer? (Q46660823)
Jump to navigation
Jump to search
scientific article published on June 28, 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Should High-Dose Interleukin-2 Still be the Preferred Treatment for Patients with Metastatic Renal Cell Cancer? |
scientific article published on June 28, 2011 |
Statements
1 reference
Should high-dose interleukin-2 still be the preferred treatment for patients with metastatic renal cell cancer? (English)
1 reference
Should High-Dose Interleukin-2 Still be the Preferred Treatment for Patients with Metastatic Renal Cell Cancer? (English)
1 reference
Robert O. Dillman
Neil M. Barth
Louis A. VanderMolen
Warren H. Fong
Khosrow K. Mahdavi
Stephanie E. McClure
28 June 2011
1 reference
1 reference
26
1 reference
3
1 reference
273-277
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference